Abstract
Purpose :
The purpose of this study is to assess the efficacy of a pterygium surgery technique involving conjunctival autograft, fibrin glue, and application of mitomycin C.
Methods :
Retrospective chart review and standard statistical analysis were performed. Records of approximately 80 patients undergoing ptergyium excision from January 2010 to June 2015, by a single surgeon, at a single institution, using the same technique, were reviewed. The main outcome measures were cosmesis and recurrence rates. Patients with at least 2 months of follow up were included in the final analysis.
Results :
A total of 67 patients met the inclusion criteria. Follow-up period ranged from 2 months to 68 months. There were zero recurrences after both primary and recurrent pterygium excision using conjunctival autograft with intraoperative mitomycin C and fibrin glue. There were no instances of persistent injection or symblepharon formation on follow-up examinations. Patients reported high levels of satisfaction on follow-up.
Conclusions :
This study highlights the efficacy of conjunctival autograft, along with mitomycin C and fibrin glue, in the treatment of primary and recurrent pterygia. With close adherence to this standardized technique, it is possible to achieve low rates of recurrence, very good cosmesis, as well as high rates of patient satisifaction.
This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.